These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 37257328)

  • 1. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
    Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
    Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
    Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
    J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway.
    Wang YY; Liu YY; Li J; Zhang YY; Ding YF; Peng YR
    Phytomedicine; 2024 Jan; 123():155172. PubMed ID: 37976694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forsythiaside A suppresses renal fibrosis and partial epithelial-mesenchymal transition by targeting THBS1 through the PI3K/AKT signaling pathway.
    Tuoheti K; Bai X; Yang L; Wang X; Cao Y; Yisha Z; Guo L; Zhan S; Wu Z; Liu T
    Int Immunopharmacol; 2024 Mar; 129():111650. PubMed ID: 38342062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hovenianin A Alleviates Hepatic Fibrosis by Inhibiting the PI3K/AKT Pathway in TGF-β1-Induced HSCs Based on Network Pharmacology and Transcriptomic Analysis.
    Kuang X; Ma T; Cai W; Yang J; Sun B; Zhang X; Liu B; Wang S; Xu F
    Chem Biodivers; 2023 Mar; 20(3):e202201110. PubMed ID: 36825591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of active components in
    Yang F; Li T; Zhang XQ; Gong Y; Su H; Fan J; Wang L; Hu QD; Tan RZ
    Ren Fail; 2024 Dec; 46(2):2375033. PubMed ID: 38967135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis.
    Dai H; Shan Y; Yu M; Wang F; Zhou Z; Sun J; Sheng L; Huang L; Sheng M
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116874. PubMed ID: 37437794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gypenosides suppress fibrosis of the renal NRK-49F cells by targeting miR-378a-5p through the PI3K/AKT signaling pathway.
    Zhang L; Wang X; He S; Zhang F; Li Y
    J Ethnopharmacol; 2023 Jul; 311():116466. PubMed ID: 37031821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism of Shenkang injection in the treatment of chronic renal failure based on the strategy of "Network pharmacology-Molecular docking-Key target validation".
    Zhou L; Wang X; Sun Z; Bao X; Xue L; Xu Z; Dong P; Xia J
    PLoS One; 2023; 18(10):e0291621. PubMed ID: 37796994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
    Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
    J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rehmannia glutinosa Libosch and Cornus officinalis Sieb herb couple ameliorates renal interstitial fibrosis in CKD rats by inhibiting the TGF-β1/MAPK signaling pathway.
    Zhu JH; Wang L; Ma ZX; Duan JA; Tao JH
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117039. PubMed ID: 37579922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zhisou powder displays therapeutic effect on chronic bronchitis through inhibiting PI3K/Akt/HIF-1α/VEGFA signaling pathway and reprograming metabolic pathway of arachidonic acid.
    Dong Y; Liu Y; Tang J; Du J; Zhuang X; Tan S; Yang Y; Yin D
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117110. PubMed ID: 37673198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
    Wang YC; Hui JR; Xiao G; Ma QL
    Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
    Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
    J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.